Non-surgical management of leiomyoma: Impact on fertility

Current Opinion in Obstetrics and Gynecology

Volumn 16, Issue 3, 2004, Pages 239-243

  Olive, David L ^a,b   Lindheim, Steven R ^a   Pritts, Elizabeth A ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b H4/628 CSC ^*  (United States)

Author keywords

Embolization; Fibroids; Infertility; Medical; Treatment

Indexed keywords

AROMATASE INHIBITOR; DANAZOL; FADROZOLE; GONADORELIN AGONIST; GONADORELIN DERIVATIVE; HORMONE DERIVATIVE; LEVONORGESTREL; MICROSPHERE; MIFEPRISTONE; PROGESTERONE RECEPTOR MODULATOR; RALOXIFENE;

ADHESION; AMENORRHEA; ANOVULATION; ATROPHY; BLEEDING; BLOOD VESSEL INJURY; CLINICAL TRIAL; DATA ANALYSIS; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; DRUG SELECTIVITY; ENDOMETRIUM; EVALUATION; FEMALE FERTILITY; FEMALE INFERTILITY; HOT FLUSH; HUMAN; HYSTERECTOMY; INHIBITION KINETICS; INTERMETHOD COMPARISON; INTRAUTERINE CONTRACEPTIVE DEVICE; LEIOMYOMA; LONG TERM CARE; MEDICAL INFORMATICS; MOLECULAR BIOLOGY; MYOMECTOMY; OUTCOMES RESEARCH; PATIENT CARE; PATIENT SATISFACTION; PREGNANCY; PREMATURE OVARIAN FAILURE; PREOPERATIVE CARE; PRIORITY JOURNAL; REVIEW; SIDE EFFECT; STANDARD; SYMPTOM; TREATMENT INDICATION; UTERINE ARTERY EMBOLIZATION; UTERUS MYOMA; VASOMOTOR DISORDER;

EMBOLIZATION, THERAPEUTIC; FEMALE; HUMANS; INFERTILITY, FEMALE; LEIOMYOMA; PREGNANCY; PREGNANCY OUTCOME; UTERINE NEOPLASMS;

EID: 2542564169     PISSN: 1040872X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001703-200406000-00006     Document Type: Review

References (35)

1. Friedman AJ, Rein MS, Harrison-Atlas D, et al. A randomized, placebo controlled, double-blind study evaluating leuprolide acetate depot treatment before myomectomy. Fertil Steril 1989; 52:728-733.
2. Fedele L, Vercellini P, Bianchi S, et al. Treatment with GnRH agonists before myomectomy and the risk of short term myoma recurrence. Br J Obstet Gynaecol 1990; 97:393-396.
3. Shaw RW. Mechanism of LHRH analogue action in uterine fibroids. Horm Res 1989; 32 (Suppl 1):150-153.
4. Golan A, Bukovsky I, Pansky M, et al. Pre-operative gonadotrophin- releasing hormone agonist treatment in surgery for uterine leiomyomata. Hum Reprod 1993; 8:450-452.
5. Zullo F, Pellicano M, De Stefano R, et al. A prospective randomized study to evaluate leuprolide acetate treatment before laparoscopic myomectomy: efficacy and ultrasonographic predictors. Am J Obstet Gynecol 1998; 178:108-112.
6. Campo S, Garcea N. Laparoscopic myomectomy in premenopausal women with and without preoperative treatment using gonadotrophin-releasing hormone analogues. Hum Reprod 1999; 14:44-48.
7. Vercellini P, Trespidi L, Zaina B, et al. Gonadotropin-releasing hormone agonist treatment before abdominal myomectomy: a controlled trial. Fertil Steril 2003; 79:1390-1395. This study used a properly sized cohort to answer an important issue, namely the value of GnRHa prior to myomectomy.
8. Lethaby A, Vollenhoven B, Sowter M. Efficacy of pre-operative gonadotrophin hormone releasing analogues for women with uterine fibroids undergoing hysterectomy or myomectomy: a systematic review. Br J Obstet Gynaecol 2002; 109:1097-1108.
9. Pritts EA. Fibroids and infertility: a systematic review of the evidence. Obstet Gynecol Surv 2001; 56:483-491.
10. Vercellini P, Maddalena S, DeGiorgi O, et al. Determinants of reproductive outcome after abdominal myomectomy for infertility. Fertil Steril 1999; 72:109-114.
11. Bozzini N, Rodrigues CJ, Petti DA, et al. Effects of treatment with gonadotropin releasing hormone agonist on the uterine leiomyomata structure. Acta Obstet Gynecol Scand 2003; 82:330-334.
12. Chegini N, Kornberg L. Gonadotropin releasing hormone analogue therapy alters signal transduction pathways involving mitogen-activated protein and focal adhesion kinases in leiomyoma. J Soc Gynecol Invest 2003; 10:21-26. This paper, along with the two below, begins to elucidate the intracellular mechanisms by which GnRHa works to reduce myoma size.
13. Chegini N, Ma C, Tang XM, Williams RS. Effects of GnRH analogues, 'add-back' steroid therapy, antiestrogen and antiprogestins on leiomyoma and myometrial smooth muscle cell growth and transforming growth factor-beta expression. Mol Hum Reprod 2002; 12:1071-1078.
14. Chegini N, Verala J, Luo X, et al. Gene expression profile of leiomyoma and myometrium and the effect of gonadotropin releasing hormone analogue therapy. J Soc Gynecol Invest 2003; 10:161-171. This paper describes an interesting use of gene microarrays to look for intracellular mechanisms associated with drug use.
15. De Leo V, la Marca A, Morgante G. Short-term treatment of uterine fibromyomas with danazol. Gynecol Obstet Invest 1999; 47:258-262.
16. La Marca A, Musacchio MC, Morgante G, et al. Hemodynamic effect of danazol therapy in women with uterine leiomyomata. Fertil Steril 2003; 79:1240-1242.
17. De Leo V, Morgante G, La Marca A, et al. A benefit-risk assessment of medical treatment for uterine leiomyomas. Drug Saf 2002; 25:759-779.
18. Eisinger SH, Meldrum S, Fiscella K, le Roux HD, Guzick DS. Low-dose mifepristone for uterine leiomyomata. Obstet Gynecol 2003; 101:243-250. This is the first large single armed trial of what is likely to be a number of studies on selective progesterone receptor modulators on fibroids.
19. Palomba S, Sammartino A, Di Carlo C, et al. Effects of raloxifene treatment on uterine leiomyomas in postmenopausal women. Fertil Steril 2001; 76:38-43.
20. Palomba S, Orio F, Morelli M, et al. Raloxifene administration in premenopausal women with uterine leiomyomas: a pilot study. J Clin Endocrinol Metab 2002; 87:1502-1508.
21. Palomba S, Russo T, Orio F, et al. Effectiveness of combined GnRH analogue plus raloxifene administration in the treatment of uterine leiomyomas: a prospective, randomized, single-blind, placebo-controlled clinical trial. Hum Reprod 2002; 17:3213-3219.
22. Shozu M, Murakami K, Segawa T, et al. Successful treatment of a symptomatic uterine leiomyoma in a perimenopausal woman with a nonsteroidal aromatase inhibitor. Fertil Steril 2003; 79:628-631.
23. Grigorieva V, Chen-Mok M, Tarasova M, Mikhailov A. Use of a levonorgestrel-releasing intrauterine system to treat bleeding related to uterine leiomyomas. Fertil Steril 2003; 79:1194-1198.
24. Pinto I, Chimeno P, Romo A, et al. Uterine fibroids: uterine artery embolization versus abdominal hysterectomy for treatment: a prospective, randomized and controlled clinical trial. Radiology 2003; 226:425-431. This was the first randomized trial to compare hysterectomy and UAE. While the design was not ideal and the size of the study was probably too small, the results do provide important comparative insights between the two treatments.
25. Pron G, Bennett J, Common A, et al. The Ontario fibroid embolization trial. Part 2. Uterine fibroid reduction and symptom relief after uterine artery embolization for fibroids. Fertil Steril 2003; 79:120-127. This and other publications by this collaborative group are the first providing prospective, multicenter information regarding UAE. The large numbers allow subgroup analyses that will aid in determining applicability of UAE to individual patients.
26. Ryu RK, Siddiqi A, Omary RA, et al. Sonography of delayed effects of uterine artery embolization on ovarian arterial perfusion and function. AJR Am J Roentgenol 2003; 181:89-92.
27. Tropeano G, Litwicka K, Di Stasi C, et al. Permanent amenorrhea associated with endometrial atrophy after uterine artery embolization for symptomatic uterine fibroids. Fertil Steril 2003; 79:132-135. This is the first report of a chilling side effect for women wishing to retain fertility after UAE.
28. Payne JF, Haney AF. Serious complications of uterine artery embolization for conservative treatment of fibroids. Fertil Steril 2003; 79:128-131.
29. Colgan TJ, Pron G, Mocarski EJM, et al. Pathologic features of uteri and leiomyomas following uterine artery embolization for leiomyomas. Am J Surg Pathol 2003; 27:167-177.
30. Fogt F, Hinds N, Zimmerman RL. Histologic features of uterine leiomyomata treated with microsphere embolization. Obstet Gynecol 2003; 102:600-602.
31. Pelage J-P, Le Dref O, Beregi J-P, et al. Limited uterine artery embolization with tris-acryl gelatin microspheres for uterine fibroids. J Vasc Interv Radiol 2003; 14:15-20. This paper is a primer on microsphere usage in UAE and what is desirable.
32. Zupi E, Pocek M, Dauri M, et al. Selective uterine artery embolization in the management of uterine myomas. Fertil Steril 2003; 79:107-111. This technique may become more popular for single fibroid patients.
33. Honda I, Sato T, Adachi H, et al. Uterine artery embolization for leiomyoma: complications and effects on fertility. Nippon Acta Radiologica 2003; 63:294-302.
34. Lefebvre G, Vilos G, Allaire C, et al. The management of uterine leiomyomas. J Obstet Gynaecol Can 2003; 25:396-418.
35. Goodwin SC. Uterine artery embolization for the treatment of uterine fibroids. Fertil Steril 2003; 79:136-137.